Europe Poultry Diagnostics Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

Europe Poultry Diagnostics Market Size

• The Europe Poultry Diagnostics Market size was valued at USD 1.18 billion in 2025 and is expected to reach USD 2.52 billion by 2033, at a CAGR of 10.00% during the forecast period
• The market growth is largely fueled by the increasing demand for efficient disease detection and monitoring in poultry farming, along with continuous advancements in diagnostic technologies, leading to improved productivity and biosecurity across commercial and small-scale poultry operations
• Furthermore, rising concerns over zoonotic diseases, food safety regulations, and the need for rapid, accurate, and user-friendly diagnostic solutions are establishing poultry diagnostics as a critical component of modern livestock management. These converging factors are accelerating the uptake of poultry diagnostics solutions, thereby significantly boosting the industry's growth

Europe Poultry Diagnostics Market Analysis

• Poultry diagnostics, encompassing a range of testing solutions for the detection of infectious diseases and health monitoring in poultry, are increasingly vital components of modern livestock management systems in both commercial farms and veterinary settings due to their role in ensuring flock health, productivity, and food safety
• The escalating demand for poultry diagnostics is primarily fueled by the rising prevalence of poultry diseases, increasing awareness regarding animal health, stringent food safety regulations, and a growing need for rapid, accurate, and cost-effective diagnostic solutions
• U.K. dominated the Europe Poultry Diagnostics Market with the largest revenue share of 37.6% in 2025, characterized by advanced veterinary healthcare infrastructure, strong regulatory frameworks, and high adoption of diagnostic technologies, while the U.S. continues to witness steady growth driven by increasing poultry production and disease surveillance initiatives
• Germany is expected to be the fastest growing region in the Europe Poultry Diagnostics Market during the forecast period due to increasing investments in animal healthcare, rising focus on food safety, and advancements in veterinary diagnostic technologies
• The virology segment dominated the largest market revenue share of 47.8% in 2025, driven by the high prevalence of viral diseases such as avian influenza and Newcastle disease

Report Scope and Europe Poultry Diagnostics Market Segmentation 

Europe Poultry Diagnostics Market Trends

“Rising Adoption of Rapid and Molecular Diagnostic Technologies in Poultry Health Management”

• A significant and accelerating trend in the global Europe Poultry Diagnostics Market is the increasing adoption of rapid and molecular diagnostic technologies for early and accurate detection of infectious diseases in poultry populations. These advanced tools are enabling faster decision-making and improved disease control across commercial poultry operations
• For instance, polymerase chain reaction (PCR)-based diagnostic tests and enzyme-linked immunosorbent assays (ELISA) are being widely utilized for the detection of diseases such as avian influenza, Newcastle disease, and salmonella, allowing timely intervention and reducing the risk of large-scale outbreaks
• The growing emphasis on biosecurity and disease surveillance is driving the integration of advanced diagnostic solutions within poultry farming practices, ensuring better monitoring of flock health and minimizing economic losses
• In addition, the development of portable and point-of-care diagnostic devices is enabling on-site testing, reducing dependency on centralized laboratories and improving turnaround times for results
• Increasing global demand for safe and high-quality poultry products is encouraging producers to adopt efficient diagnostic solutions to ensure compliance with food safety standards and regulations
• This trend toward faster, more accurate, and accessible diagnostic technologies is transforming poultry health management, with a strong focus on preventive care and disease control
• The demand for advanced poultry diagnostics is expanding across both developed and emerging markets, supported by the growth of the poultry industry and increasing awareness regarding animal health management

Europe Poultry Diagnostics Market Dynamics

Driver

“Growing Demand Driven by Increasing Poultry Production and Disease Outbreak Concerns”

• The rapid expansion of the global poultry industry, driven by increasing demand for poultry meat and eggs, is a major factor fueling the growth of the Europe Poultry Diagnostics Market. As production scales up, the need for effective disease monitoring and management becomes increasingly critical
• For instance, recurring outbreaks of avian influenza and other infectious diseases across regions such as Asia, Europe, and North America have prompted governments and poultry producers to invest in advanced diagnostic solutions to ensure early detection and containment
• The rising awareness regarding zoonotic diseases and their potential impact on human health is further encouraging the adoption of robust diagnostic systems in poultry farming
• Governments and regulatory bodies are implementing stringent guidelines related to animal health, food safety, and disease surveillance, which is driving the demand for reliable diagnostic tools
• In addition, the increasing adoption of intensive farming practices is heightening the risk of disease transmission, thereby necessitating continuous monitoring and timely diagnostics
• Technological advancements in veterinary diagnostics, including molecular testing and automated systems, are improving accuracy and efficiency, further supporting market growth
• The growing focus on export quality standards and international trade requirements is also pushing poultry producers to adopt advanced diagnostic practices
• Furthermore, increasing investments in veterinary healthcare infrastructure and research are contributing to the expansion of the Europe Poultry Diagnostics Market globally

Restraint/Challenge

“High Costs and Limited Access to Advanced Diagnostic Infrastructure”

• The high cost associated with advanced poultry diagnostic technologies remains a significant challenge, particularly for small and medium-scale poultry farmers in developing regions
• For instance, molecular diagnostic tests and automated laboratory equipment often require significant investment in infrastructure, skilled personnel, and maintenance, making them less accessible for resource-constrained operations
• Limited availability of diagnostic laboratories and inadequate veterinary infrastructure in certain regions can delay disease detection and response, increasing the risk of widespread outbreaks
• In addition, lack of awareness and technical expertise among poultry farmers regarding the benefits and use of advanced diagnostic tools can hinder market adoption
• Variability in regulatory standards and lack of harmonization across countries may also create challenges for manufacturers and service providers operating in the global market
• The time required for certain laboratory-based tests and logistical challenges in sample transportation can further impact the efficiency of disease diagnosis
• Furthermore, concerns related to the accuracy and reliability of some diagnostic methods may affect user confidence and adoption rates
• Addressing these challenges through cost-effective solutions, expansion of veterinary infrastructure, training programs, and increased awareness will be essential for ensuring sustained growth in the Europe Poultry Diagnostics Market

Europe Poultry Diagnostics Market Scope

The market is segmented on the basis of test type, disease type, and service type.

• By Test Type

On the basis of test type, the Europe Poultry Diagnostics Market is segmented into enzyme linked sorbent assay (ELISA), polymerase chain reaction tests (PCR), and others. The enzyme linked sorbent assay (ELISA) segment dominated the largest market revenue share of 44.5% in 2025, driven by its widespread use for detecting antibodies and antigens in poultry diseases. ELISA tests are highly preferred due to their cost-effectiveness, ease of use, and ability to process large sample volumes simultaneously. Poultry farms and diagnostic laboratories rely heavily on ELISA for routine screening and surveillance programs. In addition, the increasing prevalence of infectious diseases in poultry is boosting demand for reliable diagnostic methods. ELISA kits are widely available and offer standardized results, making them suitable for large-scale testing. The growing focus on food safety and disease control is also supporting segment growth. Moreover, government initiatives promoting disease monitoring are contributing to adoption. The method’s relatively quick turnaround time further enhances its appeal. Overall, ELISA remains dominant due to its affordability and efficiency in mass testing.

The polymerase chain reaction (PCR) segment is expected to witness the fastest CAGR of 21.9% from 2026 to 2033, driven by its high sensitivity and accuracy in detecting pathogens at early stages. PCR testing enables precise identification of viral and bacterial infections, even at low concentrations. The increasing demand for rapid and reliable diagnostics is a key driver for this segment. In addition, advancements in molecular diagnostic technologies are enhancing PCR capabilities. Poultry producers are increasingly adopting PCR for early disease detection and prevention. The rising incidence of zoonotic diseases is also supporting growth. Moreover, PCR tests reduce the risk of disease outbreaks by enabling timely intervention. The expansion of diagnostic laboratories is further contributing to segment growth. Increasing awareness regarding advanced diagnostic methods is another key factor. Overall, PCR is gaining traction due to its superior accuracy and reliability.

• By Disease Type

On the basis of disease type, the Europe Poultry Diagnostics Market is segmented into avian salmonellosis, avian influenza, Newcastle disease, avian mycoplasmosis, infectious bronchitis, infectious bursal disease, avian pasteurellosis, avian encephalomyelitis, avian reovirus, and chicken anemia. The avian influenza segment held the largest market revenue share of 26.3% in 2025, driven by the high prevalence and significant economic impact of the disease. Avian influenza outbreaks can lead to severe losses in poultry production, prompting extensive diagnostic testing. Governments and regulatory bodies have implemented strict surveillance programs to control the spread of the disease. The increasing global trade of poultry products is also contributing to the need for regular testing. In addition, rising awareness about zoonotic risks is boosting demand for diagnostics. Diagnostic tools for avian influenza are continuously being improved for faster detection. The involvement of international health organizations further supports monitoring efforts. Poultry farmers are investing in preventive measures to avoid outbreaks. Overall, avian influenza remains a major focus area due to its high impact on the industry.

The Newcastle disease segment is expected to witness the fastest CAGR of 22.7% from 2026 to 2033, driven by the increasing occurrence of outbreaks in developing regions. Newcastle disease is highly contagious and can cause significant mortality in poultry populations. The need for early detection and effective disease management is a key driver. Governments are promoting vaccination and diagnostic programs to control the disease. In addition, advancements in diagnostic technologies are improving detection accuracy. Poultry producers are increasingly adopting routine testing to prevent large-scale outbreaks. The expansion of poultry farming in emerging markets is also supporting growth. Moreover, rising awareness about disease control measures is contributing to adoption. The availability of rapid diagnostic kits further enhances market growth. Overall, this segment is growing rapidly due to increasing disease prevalence and preventive efforts.

• By Service Type

On the basis of service type, the Europe Poultry Diagnostics Market is segmented into bacteriology, parasitology, and virology. The virology segment dominated the largest market revenue share of 47.8% in 2025, driven by the high prevalence of viral diseases such as avian influenza and Newcastle disease. Viral infections pose significant risks to poultry health and require advanced diagnostic techniques for accurate detection. Virology services are essential for identifying and controlling outbreaks, making them a critical component of poultry diagnostics. The increasing incidence of viral diseases is a major factor supporting growth. In addition, advancements in virology testing methods are improving diagnostic efficiency. Poultry farms are increasingly relying on specialized laboratories for virus detection. Government initiatives aimed at disease surveillance are also contributing to segment growth. Moreover, the need to ensure food safety and quality is driving demand. The expansion of diagnostic infrastructure further supports adoption. Overall, virology remains dominant due to its importance in disease control.

The bacteriology segment is expected to witness the fastest CAGR of 20.8% from 2026 to 2033, driven by the rising prevalence of bacterial infections in poultry. Diseases such as salmonellosis require accurate and timely diagnosis to prevent spread. Bacteriology services help identify bacterial pathogens and guide treatment strategies. The increasing demand for safe poultry products is a key driver. In addition, regulatory requirements for food safety are supporting segment growth. Poultry producers are investing in diagnostic services to maintain quality standards. The expansion of laboratory facilities is further contributing to growth. Moreover, advancements in diagnostic techniques are improving detection capabilities. The growing awareness of disease prevention is also supporting adoption. Overall, this segment is expanding rapidly due to increasing focus on food safety and disease control.

Europe Poultry Diagnostics Market Regional Analysis

• The Europe Poultry Diagnostics Market is projected to expand at a substantial CAGR throughout the forecast period, driven by the growing emphasis on poultry health management, disease surveillance, and food safety standards
• Increasing urbanization and industrial-scale poultry farming are creating a demand for rapid and reliable diagnostic solutions to prevent outbreaks of avian diseases such as avian influenza, Newcastle disease, and salmonella
• Regulatory frameworks across the region are also encouraging the adoption of advanced diagnostic technologies to ensure animal welfare and compliance with international export standards

U.K. Europe Poultry Diagnostics Market Insight

The U.K. Europe Poultry Diagnostics Market dominated the European Europe Poultry Diagnostics Market with the largest revenue share of 37.6% in 2025, characterized by advanced veterinary healthcare infrastructure, well-established regulatory guidelines, and high adoption of diagnostic technologies. The market growth is supported by increasing investments in disease monitoring programs, widespread use of molecular and serological diagnostic tools, and government initiatives promoting poultry health management. Moreover, the rising focus on biosecurity and preventive healthcare in poultry farms is driving demand for rapid and accurate diagnostic solutions across the country.

Germany Europe Poultry Diagnostics Market Insight

The Germany Europe Poultry Diagnostics Market is expected to be the fastest growing region in Europe during the forecast period, fueled by increasing investments in animal healthcare, rising awareness of food safety, and continuous advancements in veterinary diagnostic technologies. Growth is further supported by the integration of innovative testing methodologies such as PCR-based assays and on-site rapid diagnostic kits. German poultry producers are increasingly adopting these technologies to enhance flock health monitoring, reduce disease-related losses, and comply with stringent EU regulations regarding animal health and food quality.

Europe Poultry Diagnostics Market Share

The Poultry Diagnostics industry is primarily led by well-established companies, including:

• Zoetis Inc. (U.S.)
• Boehringer Ingelheim Animal Health (Germany)
• Elanco Animal Health (U.S.)
• IDEXX Laboratories (U.S.)
• Neogen Corporation (U.S.)
• Biochek (Netherlands)
• Avivet Diagnostics (Spain)
• Synbiotics Corporation (U.S.)
• CEVA Santé Animale (France)
• FlockCheck Diagnostics (U.K.)
• Phibro Animal Health Corporation (U.S.)
• Animal Health International (U.S.)
• Aviagen Diagnostics (U.K.)
• IDT Biologika (Germany)
• Kemin Industries (U.S.)
• Thermo Fisher Scientific (U.S.)
• Neovet (France)
• Hipra (Spain)
• Phibro Animal Health Europe (Germany)

Latest Developments in Europe Poultry Diagnostics Market

• In April 2022, bioMérieux announced the launch of its GENE-UP QUANT Salmonella diagnostic test, a true non‑enrichment quantification assay for Salmonella that provides rapid, precise pathogen detection without lengthy pre‑culture steps. The test offers poultry producers faster turnaround times and accurate quantification of Salmonella contamination, helping improve operational processes and reduce antimicrobial usage and economic losses. This launch underscores the industry’s shift toward high‑sensitivity, rapid molecular tools to strengthen flock health surveillance and biosecurity protocols
• In August 2024, BioChek entered into a strategic partnership with Bio‑X Diagnostics to expand diagnostic testing capabilities in the animal health sector. The collaboration combined BioChek’s expertise in poultry and swine disease diagnostics with Bio‑X’s molecular diagnostic tools, aiming to enhance product portfolios and broaden laboratory testing offerings. This development reflects growing consolidation and cooperation among diagnostics firms to deliver comprehensive pathogen detection solutions
• In July 2024, Alveo Technologies Inc. announced the development of its Flockscreen LAMP Avian Influenza Molecular Test, a rapid, handheld molecular assay designed to detect H5N1 and related strains from cloacal and oropharyngeal samples. The platform offers poultry producers and veterinarians portable, field‑ready testing capability, accelerating diagnosis and response during outbreaks, particularly in resource‑limited or remote farm settings
• In June 2025, BioAcumen Global commercially launched the Steadfast H5‑HPAI test kit for the detection of highly pathogenic H5 avian influenza. This high‑sensitivity diagnostic tool, licensed in Southeast Asia and developed in collaboration with the Diagnostics Development Hub and international research institutes, enables detection of H5‑HPAI within three hours and supports national surveillance systems in early outbreak identification and control

SKU-21047